Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
aggressive, Agricultural, al, algorithm, answered, argued, authoritative, back, bankruptcy, biomarker, broker, byStatement, CAP, catch, categorization, chapter, Citizen, clarified, codification, College, Complaint, composition, corroborated, Court, cure, dampening, debate, declaratory, deny, devised, District, DTC, EDT, EGFR, enhanced, euro, exit, Florida, FSP, Genentech, Genzyme, goal, guard, hereditary, hierarchy, immaterial, incremental, infusional, Interactive, IVD, IVDMIA, job, joint, lack, Lehman, line, literature, Marsh, Medicaid, misuse, morein, Motion, MPI, mTOR, MYRX, nongovernmental, official, ofIn, oncologist, OnDose, opposing, optimum, orderly, Oregon, overview, paper, paradigm, payor, petition, physical, pipeline, poorer, PREZEON, pro, professional, proficiency, prognostic, pronouncement, PTEN, quoted, rata, recession, recurring, reiterated, relinquish, respond, responding, restricting, retirement, retroactively, revalued, reversal, reverse, Richard, science, Senate, signaling, simple, smaller, source, Southern, standing, sublease, supersede, tentative, theJournal, theNew, ticker, treatable, turmoil, uncured, unemployment, Union, unobservable, unprecedented, variable, Vermont, version, waived, website, welfare, Yale
Removed:
absorption, accept, addressing, administer, advance, advanced, advancing, advertising, animal, arise, arrange, assay, assist, atrial, attempt, automatically, Azixa, barrier, began, begin, bioavailability, brain, build, Burkitt, buying, carryforward, chemically, clearinghouse, clinically, collaborative, commence, commercialized, comparable, compound, concentrated, conclusive, conducting, confirm, considerable, creation, curtail, daily, decide, deficient, delayed, demonstrated, description, disagreement, disruption, diverse, documentation, dosage, drop, electronic, eligibility, eliminate, emerging, enforced, enjoy, enroll, enrolled, enrolling, enrollment, entering, entry, error, escalating, excretion, expanded, expenditure, experimental, explore, expose, exposed, extremely, facilitating, fast, fibrillation, fibrin, field, focusing, formulary, formulation, FY, generating, greatly, halt, healthy, hematologic, HHS, Historically, impair, import, inconclusive, inconsistent, inconvenient, IND, inducing, ingredient, inhibitor, initiate, initiation, insignificant, institutional, instrumentation, integrated, introducing, invested, Investigational, Jay, judicially, killing, larger, lawfully, learn, legislative, lengthy, list, living, LLP, lymphoma, managing, mandate, manufactured, manufacturing, maturation, medicinal, metabolism, mild, MMA, modeling, Modernization, modify, molecule, monitor, monitoring, move, NDA, necessitate, negative, negotiate, novelty, observed, obtained, oral, orally, outweigh, overlap, packaging, participate, passage, passed, pathway, pave, pervasive, Pharmacy, pivotal, point, power, powerful, precise, preclinical, privately, procedural, producing, profile, progressed, prolonged, promoting, promotion, proportionately, proposed, protected, protocol, prove, proximity, publicity, qualification, refinement, refractory, refusal, refuse, regimen, register, replicated, resistance, resistant, restructured, retaining, Retention, revisit, route, safe, safer, Salary, scale, selecting, sequential, setting, shelf, shorten, significance, simply, size, solid, solubility, specialist, sponsor, studied, study, submission, suffered, sufficiently, supplying, supported, susceptible, suspend, suspended, targeted, thereunder, thrombin, tolerance, toxicology, track, traditional, training, treat, tubulin, unacceptable, unannounced, unanticipated, undergoing, undergone, understood, unexpected, unmet, unpredictable, untenable, viability, viral, vivo, withdraw, withdrawal, yield
Filing tables
Filing exhibits
- 10-K Annual report
- 10.27 Employment Agreement, Dated November 5, 2002
- 10.28 Employment Agreement, Dated October 1, 2002
- 10.34 Form of Director and Executive Officer Indemnification Agreement
- 10.35 Summary of Compensation Arrangements
- 21.1 List of Subsidiaries of the Registrant
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of the CEO Pursuant to Section 302
- 31.2 Certification of the CFO Pursuant to Section 302
- 32 Certification Pursuant to Section 906
Related press release
MYGN similar filings
Filing view
External links
Exhibit 10.35
COMPENSATION OF NAMED EXECUTIVE OFFICERS
Name and Position | Fiscal 2009 Base Salary ($) | Fiscal 2009 Bonus ($) | Fiscal 2010 Base Salary ($) | |||
Peter D. Meldrum President and Chief Executive Officer | 800,000 | 1,000,000 | 832,000 | |||
Gregory C. Critchfield, M.D. President, Myriad Genetic Laboratories, Inc. | 550,000 | 415,000 | 565,000 | |||
Adrian N. Hobden, Ph.D. President, Myriad Pharmaceuticals, Inc. (1) | 535,000 | 285,000 | N/A | |||
James S. Evans Chief Financial Officer | 375,000 | 265,000 | 400,000 | |||
Mark H. Skolnick, Ph.D. (2) Chief Scientific Officer | 520,000 | 135,000 | 530,000 | |||
Richard Marsh Executive Vice-President, General Counsel and Secretary | 360,000 | 210,000 | 385,000 |
(1) | As part of the separation of MPI on June 30, 2009, Dr. Hobden ceased his employment with Myriad Genetics and transferred to the new company as Chief Executive Officer, effective June 30, 2009 |
(2) | Dr. Skolnick is compensated on an hourly basis. Base salary information reflects an annualized salary based on 2080 hours worked in a fiscal year. Actual amounts paid to Dr. Skolnick may vary significantly depending on the actual number of hours worked. |